Discovery and X-ray Crystallographic Analysis of a Spiropiperidine Iminohydantoin Inhibitor of β-Secretase

被引:48
作者
Barrow, James C. [1 ]
Stauffer, Shaun R. [1 ]
Rittle, Kenneth E. [1 ]
Ngo, Phung L. [1 ]
Yang, ZhiQiang [1 ]
Selnick, Harold G. [1 ]
Graham, Samuel L. [1 ]
Munshi, Sanjeev [2 ]
McGaughey, Georgia B. [3 ]
Holloway, M. Katharine [3 ]
Simon, Adam J. [4 ]
Price, Eric A. [4 ]
Sankaranarayanan, Sethu [4 ]
Colussi, Dennis [4 ]
Tugusheva, Katherine [4 ]
Lai, Ming-Tain [4 ]
Espeseth, Amy S. [4 ]
Xu, Min [4 ]
Huang, Qian [4 ]
Wolfe, Abigail [4 ]
Pietrak, Beth [4 ]
Zuck, Paul [5 ]
Levorse, Dorothy A. [6 ]
Hazuda, Daria [4 ]
Vacca, Joseph P. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Biol Struct, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Mol Syst, West Point, PA 19486 USA
[4] Merck Res Labs, Dept Alzheimers Res, West Point, PA 19486 USA
[5] Merck Res Labs, Dept Automated Biotechnol, West Point, PA 19486 USA
[6] Merck Res Labs, Dept Mat Characterizat, West Point, PA 19486 USA
关键词
D O I
10.1021/jm800914n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A high-throughput screen at 100.mu M inhibitor concentration for the BACE-1 enzyme revealed a novel spiropiperidine iminohydantoin aspartyl protease inhibitor template. An X-ray cocrystal structure with BACE-1 revealed a novel mode of binding whereby the inhibitor interacts with the catalytic aspartates via bridging water molecules. Using the crystal structure as a guide, potent compounds with good brain penetration were designed.
引用
收藏
页码:6259 / 6262
页数:4
相关论文
共 25 条
[1]  
CHUNG JL, 1993, Patent No. 5221675
[2]   Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases [J].
Coburn, CA ;
Stachel, SJ ;
Li, YM ;
Rush, DM ;
Steele, TG ;
Chen-Dodson, E ;
Holloway, MK ;
Xu, M ;
Huang, Q ;
Lai, MT ;
DiMuzio, J ;
Crouthamel, MC ;
Shi, XP ;
Sardana, V ;
Chen, ZG ;
Munshi, S ;
Kuo, L ;
Makara, GM ;
Annis, DA ;
Tadikonda, PK ;
Nash, HM ;
Vacca, JP ;
Wang, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6117-6119
[3]   BACE1 structure and function in health and Alzheimer's disease [J].
Cole, Sarah L. ;
Vassar, Roger .
CURRENT ALZHEIMER RESEARCH, 2008, 5 (02) :100-120
[4]   Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase [J].
Congreve, Miles ;
Aharony, David ;
Albert, Jeffrey ;
Callaghan, Owen ;
Campbell, James ;
Carr, Robin A. E. ;
Chessari, Gianni ;
Cowan, Suzanna ;
Edwards, Philip D. ;
Frederickson, Martyn ;
McMenamin, Rachel ;
Murray, Christopher W. ;
Patel, Sahil ;
Wallis, Nicola .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) :1124-1132
[5]   Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67
[6]   Aspartic proteases in drug discovery [J].
Eder, Joerg ;
Hommel, Ulrich ;
Cumin, Frederic ;
Martoglio, Bruno ;
Gerhartz, Bernd .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) :271-285
[7]   Discovery of a novel warhead against β-secretase through fragment-based lead generation [J].
Geschwindner, Stefan ;
Olsson, Lise-Lotte ;
Albert, Jeffrey S. ;
Deinum, Johanna ;
Edwards, Philip D. ;
de Beer, Tonny ;
Folmer, Rutger H. A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) :5903-5911
[8]   A century of Alzheimer's disease [J].
Goedert, Michel ;
Spillantini, Maria Grazia .
SCIENCE, 2006, 314 (5800) :777-781
[9]   Development of BACE1 inhibitors for Alzheimer's disease [J].
Guo, Tao ;
Hobbs, Doug W. .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (15) :1811-1829
[10]  
Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383